troglitazone has been researched along with bromodeoxyuridine in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahn, Y; Choi, KY; Kim, HI; Kim, JA; Oh, JW; Oh, SY; Park, KS | 1 |
| Hirose, Y; Katayama, M; Kohno, H; Kuno, T; Mori, H; Qiao, Z; Sakata, K; Shibata, T; Sugie, S; Tanaka, T; Yamada, Y; Yoshida, K | 1 |
| Barone, MV; Bonelli, P; Capaccio, D; Casamassimi, A; Ciccodicola, A; Colantuoni, V; Febbraro, A; Migliore, C; Pedicini, A; Peluso, G; Sabatino, L | 1 |
3 other study(ies) available for troglitazone and bromodeoxyuridine
| Article | Year |
|---|---|
Troglitazone activates p21Cip/WAF1 through the ERK pathway in HCT15 human colorectal cancer cells.
Topics: Blotting, Western; Bromodeoxyuridine; Cell Division; Cell Nucleus; Chromans; Colorectal Neoplasms; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA-Binding Proteins; Enzyme Inhibitors; ets-Domain Protein Elk-1; Flavonoids; HT29 Cells; Humans; Luciferases; Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins; Recombinant Fusion Proteins; Signal Transduction; Thiazoles; Thiazolidinediones; Time Factors; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2002 |
Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide.
Topics: 4-Nitroquinoline-1-oxide; Animals; Antineoplastic Agents; Bromodeoxyuridine; Carcinogens; Chromans; Cyclin D1; Cyclooxygenase 2; DNA-Binding Proteins; Incidence; Isoenzymes; Ligands; Male; Precancerous Conditions; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Inbred F344; Receptors, Cytoplasmic and Nuclear; Thiazolidinediones; Tongue; Tongue Neoplasms; Transcription Factors; Troglitazone; Tumor Cells, Cultured | 2003 |
A novel peroxisome proliferator-activated receptor gamma isoform with dominant negative activity generated by alternative splicing.
Topics: Alternative Splicing; Animals; Blotting, Western; Bromodeoxyuridine; Caco-2 Cells; Cell Nucleus; Cell Proliferation; Chromans; Colorectal Neoplasms; COS Cells; DNA, Complementary; Exons; Genes, Dominant; Genes, Reporter; Genetic Vectors; Humans; In Vitro Techniques; Introns; Ligands; Luciferases; Mice; Microscopy, Fluorescence; Models, Genetic; NIH 3T3 Cells; Open Reading Frames; PPAR gamma; Protein Biosynthesis; Protein Isoforms; Protein Structure, Tertiary; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Thiazolidinediones; Transcriptional Activation; Transfection; Troglitazone | 2005 |